NCT05198895View on ClinicalTrials.gov

Safety and Performance of the Glyconics-SX System

NACompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

October 19, 2022

Study Completion Date

October 28, 2022

Conditions

Diabetes Mellitus, Type 2

Interventions

DEVICE

Near-infrared (NIR)

NIR spectral assessment of glycated nail keratin vs glycated haemoglobin (HbA1c)

Trial Locations (1)

Unknown

Leicester Diabetes Centre, Leicester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Glyconics Ltd

INDUSTRY

NCT05198895 - Safety and Performance of the Glyconics-SX System | Biotech Hunter | Biotech Hunter